Skip to main content
Premium Trial:

Request an Annual Quote

MorphoSys Buys Sloning BioTechnology for $26.5M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German biotech firm MorphoSys today announced it has acquired Sloning BioTechnology, which is developing new methods of synthetic biology, for €19 million ($26.5 million).

MorphoSys will now be the sole source for Sloning's Slonomics technology, which enables the precise construction of protein libraries "comprising defined mixtures of amino acids at predetermined positions with unprecedented speed," MorphoSys said in a statement, adding that the technology represents a new and flexible approach for generating optimized proteins, such as antibodies.

Integration of the Slonomics technology in MorphoSys' existing antibody platform is expected to improve the success rate for new drug candidate development to the point where 50 percent of new projects will reach clinical development, MorphoSys said.

The company will also use Sloning's technology to develop therapeutic and diagnostic antibodies.

Sloning was founded in 2001 and is headquartered in Puchheim, Germany.

MorphoSys said the deal is not material to its financial guidance for 2010.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.